Lotte Card, Osstem controversies deepen scrutiny of MBK

MBK Partners is facing growing scrutiny over its management of portfolio companies, as controversies spread from Homeplus’ court-led rehabilitation to a business suspension at Lotte Card and workforce restructuring at Osstem Implant. Critics say the incidents raise questions about governance and internal controls at MBK-controlled businesses, as well as whether cost-cutting and investment recovery are being prioritized over long-term corporate value. The Financial Services Commission on Friday f

By The Korea Herald